Related references
Note: Only part of the references are listed.Clinical Validation of KRAS, BRAF, and EGFR Mutation Detection Using Next-Generation Sequencing
Ming-Tseh Lin et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2014)
Evaluation of droplet digital PCR for characterizing plasmid reference material used for quantifying ammonia oxidizers and denitrifiers
Lianhua Dong et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2014)
Effect of low-frequency KRAS mutations on the response to anti-EGFR therapy in metastatic colorectal cancer
D. Tougeron et al.
ANNALS OF ONCOLOGY (2013)
Multiplex Picodroplet Digital PCR to Detect KRAS Mutations in Circulating DNA from the Plasma of Colorectal Cancer Patients
Valerie Taly et al.
CLINICAL CHEMISTRY (2013)
Sensitive Detection of KRAS Mutations Using Enhanced-ice-COLD-PCR Mutation Enrichment and Direct Sequence Identification
Alexandre How Kit et al.
HUMAN MUTATION (2013)
Stool DNA testing for the detection of pancreatic cancer Assessment of Methylation Marker Candidates
John B. Kisiel et al.
CANCER (2012)
Nanofluidic Digital PCR for KRAS Mutation Detection and Quantification in Gastrointestinal Cancer
Daniel Azuara et al.
CLINICAL CHEMISTRY (2012)
Next-Generation Stool DNA Test Accurately Detects Colorectal Cancer and Large Adenomas
David A. Ahlquist et al.
GASTROENTEROLOGY (2012)
Large duct type invasive adenocarcinoma of the pancreas with microcystic and papillary patterns: a potential microscopic mimic of non-invasive ductal neoplasia
Pelin Bagci et al.
MODERN PATHOLOGY (2012)
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
Sandra Misale et al.
NATURE (2012)
All about KRAS for clinical oncology practice: Gene profile, clinical implications and laboratory recommendations for somatic mutational testing in colorectal cancer
Helena Linardou et al.
CANCER TREATMENT REVIEWS (2011)
Increased Detection Sensitivity for KRAS Mutations Enhances the Prediction of Anti-EGFR Monoclonal Antibody Resistance in Metastatic Colorectal Cancer
Francesca Molinari et al.
CLINICAL CANCER RESEARCH (2011)
Ice-COLD-PCR enables rapid amplification and robust enrichment for low-abundance unknown DNA mutations
Coren A. Milbury et al.
NUCLEIC ACIDS RESEARCH (2011)
Comparative analysis of pyrosequencing and QMC-PCR in conjunction with high resolution melting for KRAS/BRAF mutation detection
Salih Ibrahem et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2010)
COLD-PCR: a new platform for highly improved mutation detection in cancer and genetic testing
Jin Li et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2009)
KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab
Astrid Lievre et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer
Rafael G. Amado et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Enabling personalized cancer medicine through analysis of gene-expression patterns
Laura J. van 't Veer et al.
NATURE (2008)
K-ras mutations and benefit from cetuximab in advanced colorectal cancer
Christos S. Karapetis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Implementation of a robotized real-time PCR setup for the use of the Quantifiler™ Human DNA Quantification Kit
Ralph Schwenzer et al.
FORENSIC SCIENCE INTERNATIONAL GENETICS SUPPLEMENT SERIES (2008)
Analytical validation of genotyping assays in the biomarker laboratory
Jennifer A. Isler et al.
PHARMACOGENOMICS (2007)
Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC (RASCAL) and TP53CRC collaborative studies
Antonio Russo et al.
ANNALS OF ONCOLOGY (2005)
K-ras and p16 aberrations confer poor prognosis in human colorectal cancer
M Esteller et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
